Revorf Company
Revorf is developing a testing business and a diagnostic drug development of support drug discovery and support business in relation to the neo-self theory, which is a new mechanism that explains the basis of autoimmune diseases. The methods are created by combining proprietary gene detection analysis technology, such as RNA, protein information analysis technology, data analysis, and artificial intelligence technology.
Founded Date:
2019-11-11 00:00:00
Industry:
BioPharma AI
Headquarters:
Tokyo,Tokyo,Japan,Asia
Technology:
Biomarker Discovery & Validation
Funding Status:
private